JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, T.
Right arrow Articles by Suzuki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, T.
Right arrow Articles by Suzuki, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 33, 20156-20159, Nov, 1990

Further localization of binding sites for thrombin and protein C in human thrombomodulin

T Hayashi, M Zushi, S Yamamoto and K Suzuki
Division of Enzyme Cytology, University of Tokushima, Japan.

To elucidate the binding sites for thrombin and protein C in the six epidermal growth factor (EGF) domains of human thrombomodulin, recombinant mutant proteins were expressed in COS-1 cells. Mutant protein EGF456, which contains the fourth, fifth, and sixth EGF domains from the NH2 terminus of thrombomodulin, showed complete cofactor activity in thrombin-catalyzed protein C activation, as did intact thrombomodulin or elastase-digested thrombomodulin. EGF56, containing the fifth and sixth EGF domains, did not have cofactor activity; but EGF45, containing the fourth and fifth EGF domains, had about one-tenth of the cofactor activity of EGF456. Thrombin binding to attached recombinant thrombomodulin (D123) was inhibited by EGF45 as well as by EGF56. A synthetic peptide (ECPEGYILDDGFICTDIDE), corresponding to Glu- 408 to Glu-426 in the fifth EGF domain, inhibited thrombin binding to attached thrombomodulin (D123) with an apparent Ki of 95 microM. At Ca2+ concentrations of 0.25-0.3 mM, intact protein C was maximally activated by thrombin in the presence of EGF45, EGF456, or EGF1-6, which contains the first to sixth EGF domains; but such maximum cofactor activity was not observed when gamma-carboxyglutamic acid- domainless protein C was used. These findings suggest that: 1) thrombin binds to the latter half of the fifth EGF domain; and 2) protein C binds to the fourth EGF domain of thrombomodulin through Ca2+ ions.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Xu, L. A. Bush, A. O. Pineda, S. Caccia, and E. Di Cera
Thrombomodulin Changes the Molecular Surface of Interaction and the Rate of Complex Formation between Thrombin and Protein C
J. Biol. Chem., March 4, 2005; 280(9): 7956 - 7961.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. O. Pineda, A. M. Cantwell, L. A. Bush, T. Rose, and E. Di Cera
The Thrombin Epitope Recognizing Thrombomodulin Is a Highly Cooperative Hot Spot in Exosite I
J. Biol. Chem., August 23, 2002; 277(35): 32015 - 32019.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kokame, X. Zheng, and J. E. Sadler
Activation of Thrombin-activable Fibrinolysis Inhibitor Requires Epidermal Growth Factor-like Domain 3 of Thrombomodulin and Is Inhibited Competitively by Protein C
J. Biol. Chem., May 15, 1998; 273(20): 12135 - 12139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. C. Y. Liaw, J. C. Fredenburgh, A. R. Stafford, A. Tulinsky, R. C. Austin, and J. I. Weitz
Localization of the Thrombin-binding Domain on Prothrombin Fragment 2
J. Biol. Chem., April 10, 1998; 273(15): 8932 - 8939.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Haruta, S. Kobayashi, S. Hirose, A. Horiai, M. Ohyanagi, M. Tanaka, T. Kawano, T. Shirai, Y. Takasaki, and H. Hashimoto
Monoclonal Anti-Cardiolipin Antibodies from New Zealand Black x New Zealand White F1 Mice React to Thrombomodulin
J. Immunol., January 1, 1998; 160(1): 253 - 258.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. L. Mac Hale, N. Nathan, and M. D'Ambra
Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin
Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 319 - 332.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Adler, M. H. Seto, D. E. Nitecki, J.-H. Lin, D. R. Light, and J. Morser
The Structure of a 19-Residue Fragment from the C-loop of the Fourth Epidermal Growth Factor-like Domain of Thrombomodulin
J. Biol. Chem., October 6, 1995; 270(40): 23366 - 23372.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.